Schulman Ivonne Hernandez, Raij Leopoldo
University of Miami Miller School of Medicine, Nephrology-Hypertension Section, Veterans Affairs Medical Center, 1201 Northwest 16 Street, Room A-1009, Miami, FL 33125, USA.
Curr Hypertens Rep. 2008 Jun;10(3):188-93. doi: 10.1007/s11906-008-0036-8.
Angiotensin (Ang) II exerts its important physiologic functions through two distinct receptor subtypes, the type 1 (AT1) and type 2 (AT2) receptors. AT1 and AT2 receptors have demonstrated counterregulatory interactions in the cardiovascular and renal systems. The cross-talk between AT1 and AT2 receptors has been suggested to participate in regulating blood pressure, cardiovascular growth, fibrosis, and remodeling, as well as renal blood flow, growth, fibrosis, and sodium excretion. The AT1 receptor is distributed ubiquitously and abundantly in adult tissues, whereas expression of the AT2 receptor is high in the fetus but low in adult tissues. However, mounting evidence indicates that AT2 receptor cardiovascular expression increases in response to injury and AT1 receptor blocker therapy. This article reviews recent experimental and clinical data elucidating the role of the AT2 receptor in cardiovascular and renal homeostasis.
血管紧张素(Ang)II 通过两种不同的受体亚型,即 1 型(AT1)和 2 型(AT2)受体发挥其重要的生理功能。AT1 和 AT2 受体在心血管系统和肾脏系统中表现出相互调节的作用。有研究表明,AT1 和 AT2 受体之间的相互作用参与调节血压、心血管生长、纤维化和重塑,以及肾血流量、生长、纤维化和钠排泄。AT1 受体在成体组织中广泛且大量分布,而 AT2 受体在胎儿中表达较高,但在成体组织中表达较低。然而,越来越多的证据表明,AT2 受体在心血管系统中的表达会随着损伤和 AT1 受体阻滞剂治疗而增加。本文综述了近期阐明 AT2 受体在心血管和肾脏稳态中作用的实验和临床数据。